On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
On Oct. 12, 2024, the Sabin Vaccine Institute announced it had delivered a second shipment of ~1000 more…
On Oct. 10, 2024, health officials from the U.S. Centers for Disease Control and Prevention announced they had…
On Oct. 10, 2024, a report by the World Health Organization (WHO) found that vaccines against 24 pathogens…
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
On Oct. 9, 2024, Novavax announced that the European Commission granted Marketing Authorization for Novavax’s updated 2024-2025 Nuvaxovid™…
On Oct. 8, 2024, the Pan American Health Organization (PAHO) announced an epidemiological alert and urged countries in…
On Oct. 4, 2024, the World Health Organization (WHO) announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine…
On Oct. 3, 2024, the California Department of Public Health (CDPH) reported that the human case previously under…
On Oct. 3, 2024,the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP)…
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
On Sept. 27, 2024, the World Health Organization (WHO) announced the recommendations for the viral composition of influenza…
On Sept. 25, 2024, drug-resistant pathogens could jeopardise the food supply of over two billion people and increase…
On Sept. 25, 2024, U.S. healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to…
On Sept. 24, 2024, U.S. President Joe Biden announced the donation of 1 million mpox vaccine doses and…
On Sept. 23, 2024, researchers from Columbia University reported that a study of Children born during the first…
On Sept. 20, 2024, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is…
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
On Sept. 19, 2024, the European Medical Agency (EMA) announced it had recommended extending the indication of the…
On Sept. 19, 2024, a U.S. population-based birth cohort study was released that showed that 53.4% of babies…
On Sept. 19, 2024, an international team of researchers announced a study that genetically traced the epicenter of…
On Sep. 13. 2024, Novavax announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to…
On Sep. 11, 2024, researchers at UTHealth Houston and Baylor College of Medicine reported that Avian influenza A(H5N1)…
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
On Sep. 6, 2024, the Centers for Disease Control and Prevention (CDC) confirmed a human case of avian…
On Sep. 4, 2024, researcher led by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University…
On Sep. 2, 2024, the World Health Organization (WHO) confirmed that a laboratory-confirmed case of human infection with…
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
On Aug. 30, 2024, the United Nations (UN) announced that polio vaccination will begin for some 640,000 children…